Abiopharma

News list

📋 Jenne Kyle (Director) plans to sell 58K shares of IONIS PHARMACEUTICALS INC (at $75.57 each, total $4.4M) Filed: Mar 10, 2026 | ID: 000093

Full text

News bot March 10, 2026, 8:01 p.m.
📋 Form 144 Filing: Jenne Kyle

Company: IONIS PHARMACEUTICALS INC

Filing Date: 2026-03-10

Relationship: Director
Planned Sale Details:
- Security: Common Stock
- Shares to be Sold: 58,253
- Price per Share: $75.57
- Total Value: $4,402,296.00
- Planned Sale Date: 2026-03-10
- Broker: Stifel Nicolaus & Company Inc
- Exchange: Nasdaq
Additional Information:
- SEC File Number: 000-19125
- Issuer Contact Phone: 7609319200
- Issuer Address: 2855 GAZELLE COURT, CARLSBAD, CA, 92010
- Broker Address: 501 N Broadway, St. Louis, MO, 63102
- Shares Outstanding: 165190000.0
- Number of Securities to be Sold: 2
- Number of Past Sales: 1
- Signature: /s/ Luca Lotito, as a duly authorized representative of STIFEL, as attorney-in-fact for Kyle Jenne